Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Synthesis and electronic properties of oxidized benzo[1,2-b:4,5-b']dithiophenes.

Pappenfus TM, Seidenkranz DT, Lovander MD, Beck TL, Karels BJ, Ogawa K, Janzen DE.

J Org Chem. 2014 Oct 3;79(19):9408-12. doi: 10.1021/jo5017585. Epub 2014 Sep 19.

PMID:
25198532
2.

Reproductive and metabolic phenotype of a mouse model of PCOS.

van Houten EL, Kramer P, McLuskey A, Karels B, Themmen AP, Visser JA.

Endocrinology. 2012 Jun;153(6):2861-9. doi: 10.1210/en.2011-1754. Epub 2012 Feb 14.

PMID:
22334715
3.

Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary.

Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, Uilenbroek JT, Grootegoed JA, Themmen AP.

Endocrinology. 2002 Mar;143(3):1076-84.

PMID:
11861535
4.

Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary.

Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP.

Endocrinology. 2001 Nov;142(11):4891-9.

PMID:
11606457
5.

Apoptotic and proliferative changes during induced atresia of pre-ovulatory follicles in the rat.

Durlinger AL, Kramer P, Karels B, Grootegoed JA, Uilenbroek JT, Themmen AP.

Hum Reprod. 2000 Dec;15(12):2504-11.

PMID:
11098018
6.

Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary.

Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP.

Endocrinology. 1999 Dec;140(12):5789-96.

PMID:
10579345
7.

Significance of oestradiol for follicular development in hypogonadotrophic immature rats treated with FSH and hCG.

Uilenbroek JT, Kramer P, Karels B, de Jong FH.

J Reprod Fertil. 1997 Jul;110(2):231-6.

PMID:
9306975
8.

Recombinant FSH-induced follicle development in immature rats treated with an LHRH antagonist:a direct effect of RU486 on follicular atresia.

Uilenbroek JT, Kramer P, van Leeuwen EC, Karels B, Timmerman MA, de Jong FH, de Leeuw R.

J Endocrinol. 1996 Jul;150(1):85-92.

PMID:
8708566
9.

A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct.

Baarends WM, van Helmond MJ, Post M, van der Schoot PJ, Hoogerbrugge JW, de Winter JP, Uilenbroek JT, Karels B, Wilming LG, Meijers JH, et al.

Development. 1994 Jan;120(1):189-97.

11.
13.

Effect of thyroid status and paraventricular area lesions on the release of thyrotropin-releasing hormone and catecholamines into hypophysial portal blood.

Rondeel JM, de Greef WJ, van der Schoot P, Karels B, Klootwijk W, Visser TJ.

Endocrinology. 1988 Jul;123(1):523-7.

PMID:
3133200
14.
15.

Levels of LH-releasing hormone in hypophysial stalk plasma during an oestrogen-stimulated surge of LH in ovariectomized rats.

de Greef WJ, de Koning J, Tijssen AM, Karels B.

J Endocrinol. 1987 Mar;112(3):351-9.

PMID:
3104524
16.

Supplemental Content

Loading ...
Support Center